← Leaderboards
Julia K Kofler
University Of Pittsburgh At Pittsburgh
$9,913,650
Attributed
$15,977,315
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,977,315 · 10
By mechanism
R01$10,041,439 · 3
P30$2,395,448 · 3
P50$1,585,054 · 2
U24$1,531,729 · 1
UE5$423,645 · 1
Top collaborators
- Robert A Sweet9 shared
- Lirong Wang9 shared
- Katie Lunnon4 shared
- Constantinos George Hadjipanayis2 shared
- Page Buckhannan Pennell2 shared
- Tamer S Ibrahim1 shared
- Milos D Ikonomovic1 shared
- Joseph Mettenburg1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- William E Klunk$26,129,826
- Oscar L. Lopez$26,660,804
- Nam V Vo$9,841,127
- Milos D Ikonomovic$11,868,106
- Judith A Saxton$8,385,766
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposNeuropathologyS DiseasePathologyPhenotypeBrainAutopsyGeneticResearch PersonnelCohortTissue SampleNeurobiologyS Disease RiskLinkTissuesImpaired CognitionMolecularSynapsesDisease ProgressionNerve DegenerationDigital ImagingEndophenotypeInterestBrain Tissue
Grant awards (37)
Multimodal in Vivo and Postmortem Analysis of ARIA-Relevant Pathophysiology$1,531,729
U24 · FY2025 · NS · contact PI
Accelerating Treatment Development for Psychosis in AD: MODEL-AD+P$945,233
R01 · FY2025 · MH
Neuropathology Core$506,518
P30 · FY2025 · AG · contact PI
Genetic and molecular correlates of white matter pathology in Alzheimers disease$462,691
R01 · FY2025 · AG · contact PI
N3-PREP (Neurology, Neurosurgery, & Neuropathology Pitt Research Education Program)$207,749
UE5 · FY2025 · NS
Accelerating Treatment Development for Psychosis in AD: MODEL-AD+P$787,106
R01 · FY2024 · MH
Genetic and molecular correlates of white matter pathology in Alzheimers disease$607,284
R01 · FY2024 · AG · contact PI
Neuropathology Core$455,996
P30 · FY2024 · AG · contact PI
N3-PREP (Neurology, Neurosurgery, & Neuropathology Pitt Research Education Program)$215,896
UE5 · FY2024 · NS
Accelerating Treatment Development for Psychosis in AD: MODEL-AD+P - Supplement$158,127
R01 · FY2024 · MH
Accelerating Treatment Development for Psychosis in AD: MODEL-AD+P$787,106
R01 · FY2023 · MH
Genetic and molecular correlates of white matter pathology in Alzheimers disease$607,284
R01 · FY2023 · AG · contact PI
Neuropathology Core$495,020
P30 · FY2023 · AG · contact PI
A multi-omic approach to elucidate novel disease mechanisms and biomarkers for psychosis in Alzheimerâs disease$275,172
R01 · FY2023 · AG
Genetic and molecular correlates of white matter pathology in Alzheimers disease$617,529
R01 · FY2022 · AG · contact PI
Synaptic Resilience to Psychosis in Alzheimer Disease$589,988
R01 · FY2022 · MH
Neuropathology Core$377,526
P30 · FY2022 · AG · contact PI
Synaptic Resilience to Psychosis in Alzheimer Disease$589,988
R01 · FY2021 · MH
Genetic and molecular correlates of white matter pathology in Alzheimers disease$521,155
R01 · FY2021 · AG · contact PI
A multi-omic approach to elucidate novel disease mechanisms and biomarkers for psychosis in Alzheimerâs disease$425,721
R01 · FY2021 · AG
Neuropathology Core$280,194
P30 · FY2021 · AG · contact PI
Synaptic Resilience to Psychosis in Alzheimer Disease$589,988
R01 · FY2020 · MH
A multi-omic approach to elucidate novel disease mechanisms and biomarkers for psychosis in Alzheimerâs disease$486,919
R01 · FY2020 · AG
Neuropathology Core$280,194
P30 · FY2020 · AG · contact PI
Synaptic Resilience to Psychosis in Alzheimer Disease$745,305
R01 · FY2019 · MH
A multi-omic approach to elucidate novel disease mechanisms and biomarkers for psychosis in Alzheimerâs disease$379,062
R01 · FY2019 · AG
Core D: Neuropathology Core$132,249
P50 · FY2019 · AG · contact PI
Synaptic Resilience to Psychosis in Alzheimer Disease$465,781
R01 · FY2018 · MH
Core D: Neuropathology Core$132,248
P50 · FY2018 · AG · contact PI
Core D: Neuropathology Core$132,249
P50 · FY2017 · AG · contact PI
Core D: Neuropathology Core$132,249
P50 · FY2016 · AG · contact PI
Core D: Neuropathology Core$132,249
P50 · FY2015 · AG · contact PI
ALTERATIONS OF MICROGLIAL PHENOTYPE AND FUNCTION IN AGING AND ALZHEIMER'S DISEASE$178,613
P50 · FY2014 · AG · contact PI
ALTERATIONS OF MICROGLIAL PHENOTYPE AND FUNCTION IN AGING AND ALZHEIMER'S DISEASE$168,678
P50 · FY2013 · AG · contact PI
ALTERATIONS OF MICROGLIAL PHENOTYPE AND FUNCTION IN AGING AND ALZHEIMER'S DISEASE$182,220
P50 · FY2012 · AG · contact PI
ALTERATIONS OF MICROGLIAL PHENOTYPE AND FUNCTION IN AGING AND ALZHEIMER'S DISEASE$205,648
P50 · FY2011 · AG · contact PI
ALTERATIONS OF MICROGLIAL PHENOTYPE AND FUNCTION IN AGING AND ALZHEIMER'S DISEASE$188,651
P50 · FY2010 · AG · contact PI